Trademark Overview
On Friday, May 30, 2025, a trademark application was filed for DARE TO DREAM PROJECT with the United States Patent and Trademark Office. The USPTO has given the DARE TO DREAM PROJECT trademark a serial number of 99209802. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, May 30, 2025. This trademark is owned by The Leukemia & Lymphoma Society, Inc.. The DARE TO DREAM PROJECT trademark is filed in the Advertising, Business and Retail Services, Personal, Legal & Social Services, Insurance & Financial Services, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing patient education services in the nature of classes, courses, and workshops in the field of blood cancer
Accepting and administering monetary charitable contributions in the field of blood cancer; providing financial sponsoring for clinical trials in the field of blood cancer; charitable fundraising to support blood cancer research; charitable fundraising services for promoting research, education, and other activities relating to blood cancer and blood cancer research
Promoting the interests of blood cancer patients and medical professionals in the field of blood cancer; administration and management of research grants in the field of blood cancer; promoting the interests of blood cancer patients and medical professionals in the field of blood cancer by means of public advocacy; promoting public awareness of blood cancer by means of public advocacy
Providing personal support services for patients and families of patients with blood cancer, namely, emotional counseling and emotional support in the field of blood cancer
Providing medical counseling and information about medical terms and clinical trials to patients, families, and healthcare providers in the field of blood cancer, including helping children, patients, caregivers, parents and physicians to identify appropriate clinical trials for children with blood cancer; providing information in the field of blood cancer treatment; providing nutritional consultations to patients, families, and caregivers in the field of blood cancer